Method for the preparation of (.+-.)-calanolide A and intermedia

Chemistry: molecular biology and microbiology – Process of utilizing an enzyme or micro-organism to destroy... – Resolution of optical isomers or purification of organic...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435125, C12P 4100

Patent

active

058693246

ABSTRACT:
A method of preparing (.+-.)-calanolide A, 1, a potent HIV reverse transcriptase inhibitor, from chromene 4 is provided. Useful intermediates for preparing (.+-.)-calanolide A and its derivatives are also provided. According to the disclosed method, chromene 4 intermediate was reacted with acetaldehyde diethyl acetal or paraldehyde in the presence of an acid catalyst with heating, or a two-step reaction including an aldol reaction with acetaldehyde and cyclization either under acidic conditions or neutral Mitsunobu conditions, to produce chromanone 7. Reduction of chromanone 7 with sodium borohydride, in the presence of cerium trichloride, produced (.+-.)-calanolide A. A method for resolving (.+-.)-calanolide A into its optically active forms by a chiral HPLC system or by enzymatic acylation and hydrolysis is also disclosed. Finally, a method for treating or preventing viral infections using (.+-.)-calanolide A or (-)-calanolide A is provided.

REFERENCES:
patent: 5447865 (1995-09-01), Wong et al.
Khilevich et al., (1996) Chemical Abstracts, vol. 125, No. 21, Abstract No. 275454.
Khilevich et al., (1996) "Synthesis of (+)-Calanolide A. and anti-HIV agent, via enzyme catalized resolution of the aldol products." Tetrahedron Asymmetry, vol. 7, No. 11, pp. 3315-3326.
Palmer et al., (1995) "Synthesis of the Calophyllum Coumarines. Part 2.", Journal Of The Chemical Society, Perkin Trans. I, pp. 3135-3152.
Rehder et al., (1996), Chemical Abstracts, vol. 125, No. 3, Abstract No. 300646.
Galinis et al., (1996) "Structre-activity modifications of the HIV inhibitors (+)-Calanolide A and (-) Calanolide B.", Journal of Medicinal Chemistry, vol. 39, pp. 4507-4510.
Zembower et al., (1997) "Structural Anbalogues of the Calanolide Anti-HIV Agents. Modification of the Trans-10, 11-dimethyldihydropyran-12-o1 Ring (Ring C)." Journal of Medicinal Chemistry, vol. 40, No. 6, pp. 1005-1017.
Brookmeyer, R. (1991), Science, vol. 253, pp. 37-42.
Bruan et al. (1990), Annu. Rev. Microbiol., vol. 44, pp. 555-577.
Weislow et al. (1990), J. Natl. Cancer Inst., vol. 81, 577-586.
Mitsuya et al. (1990), Science, vol. 249, pp. 1533-1544.
Petteway et al. (1991), Trends Pharmacol. Sci., vol. 12, pp. 28-34.
Richman, D.D. (1991), Annual. Rev. Med., vol. 42, pp. 69-90.
Hadden, J.W. (1991), Trends Pharmacol. Sci., vol. 12, pp. 107-111.
Huff, J.R. (1991), J. Med. Chem., vol. 34, pp. 2305-2314.
De Clercq, E. (1992), AIDS Research and Human Retroviruses, vol. 8, pp. 119-134.
Kashman et al. (1992), J. Med. Chem., vol. 35, pp. 2735-2743.
Chenera et al. (1993), J. Org. Chem., vol. 58, pp. 5605-5606.
Sethna et al. (1953), Organic Reactions, Chapter 1, pp. 1-58.
Crombie et al. (1987), Chem. Soc., vol. 1, pp. 317-330.
Barton et al. (1990), Tetrahedron Letters, Wol. 31, pp. 7449-74542.
Szell et al. (1969), Helvetica Chimica Acta, vol. 52, pp. 2636-2641.
Fung et al. (1978), J. Org. Chem., vol. 43, pp. 3977-3979.
Gemal et al. (1981), J. Am. Chem. Soc., vol. 103, pp. 5454-5459.
Palmer et al. (1994), "Synthesis of the Calophyllum coumarins," Tet. Letters, vol. 35, pp. 5363-5366.
Kashman et al. (1992) "The Calanolides, a Novel HIV-Inhibitory Class of Coumarin Derivatives from the Tropical Rainforest Tree, Calophyllum lanigerum," J. Med. Chem., vol. 35, pp. 2735-2743.
Games et al. (1972), "Identification of 4-Phenyl and 4-Alkycoumarins in Mammea Americana L., Mammea Africana G. Don and Calophyllum Inophyllum by Gas Chromatography-Mass Spectrometry," Tet. Letters, vol. 31, pp. 3187-3190.
Crombie et al. (1966), "Isolation and Structure of Mammea B/BA, B/BB, B/BC and C/BB: A Group of 4-m-Propyl-and 4-n-Amyl-Coumarin Extractives of Mammea Americana L., " Tet. Letters, vol. 2, pp. 151-156.
Cooper et al. (1994), GR15987 and Related Analogues as Highly Potent, Orally Active Non-Peptide Neurokinin NK.sub.2 Receptor Antagonists, Bioorganic & Med. Chem. Lett., vol. 4, pp. 1951-1956.
Hizi et al. (1993), "Specific Inhibition of the Reverse Transcriptase of Human Immunodeficiency Virus type 1 and the Chimeric Enzymes of Human Immunodeficiency Virus Type 1 and 2 by Nonnucceloside Inhibitors," Antimicrobial Agents and Chemotherapy, vol. 37, pp. 1037-1042.
Buckheit et al. (1995), "Comparative Anti-HIV Evaluation of Diverse HIV-1-Specific Reverse Transcriptase Inhibitor-Resistant Virus Isolates Demonstrates the Existence of Distinct Phenotypic Subgroups,"Antiviral Research, vol. 26, pp. 117-132.
Buckheit et al. (1995), "Resistance to by Mutations at Multiple Sites in the HIV-1 Reverse Transcriptase," Virology, vol. 210, pp. 186-193.
Boyer et al. (1993), "Analysis of Nonnuccleoside Drug-Resistant Variants of Human Immunodeficiency Viirus Type 1 reverse Transcriptase,"J. Viroloogy, vol. 67, pp. 2412-2420.
McKee et al. (1995), "The Pseudocalanolides: Structures Revision of Calanolides C and D," J. Natural Products, vol. 58, pp. 916-920.
Kucherenko et al. (1995), "Novel Approach for Synthesis of (.+-.)-Calanolide A and Its Anti-HIV Activity," Tet. Letters, vol. 36, pp. 5475-5478.
Gustafson et al. (1994), "Calanone, a Novel Coumarin From Calophyllum tesysmannii," Tet. Letters, vol. 35, pp. 5821-5824.
Kashman et al. (1993), "The Calanolides, a Novel HIV-Inhibitory Class of Coumarin Derivatives from the Tropical Rainforest Tree, Calophyllum lanigerum," J. Med. Chem., vol. 36, p. 1110.
Bader et al. (1991), "Oxathiin Carboxanilide, a Potent Inhibitor of Human Immunodeficiency Virus Reproduction," Proc. Natl. Acad. Sci. USA, vol. 88, pp. 6740-6744.
Borch et al. (1971), "The Cyanohydridoborate Anion as a Selective Reducing Agent," J. Amer. Chem. Soc., vol. 93, pp. 2897-2904.
Buckheit et al. (1994), "Cell-Based and Biuochemical Analysis of the Anti-HIV Activity of Combination of 3'-Azido-3'-Deoxythymidine and Analogues of TIBO," Antiviral Chemistry & Chemotherapy, vol. 5(1), pp. 35-42.
Castro, B.R. (1983), "Replacement of Alcoholic Hydroxyl Groups by Halogens and Other Nucleophiles via Oxyphosphonium Intermediates," Org. React., vol. 29, pp. 1-162.
Feuer et al. (1965), "The Reduction of Oximes with Diborane. A New Synthesis of N-Monosubstituted Hydroxylamines," J. Org. Chem., vol. 30, pp. 2877-2880.
Feuer and Braunstein (1969), "The Reduction of Oximes, Oxime Ethers, and Oxime Esters with Diborane. A Novel Synthesis of Amines," J. Org. Chem., vol. 34, pp. 1817-1821.
Hudlicky, M. (1988), "Flourination with Diethylaminosulfur Trifluoride and Related Aminofluorosulfuranes," Org. React., vol. 35, pp. 513-637.
Hughes, D.L. (1992), "The Mistsunobu Reaction," Organic Reaction, vol. 42, pp. 335-656.
Kukla et al. (1991), "Sysnthesis and Anti-HIV-1 Activity of (TIBO) Derivatives," J. Medicinal Chemistry, vol. 34, pp. 746-751.
Lin et al. (1994), "sythesis and Biolofical Evaluation of 2',3'-Dideoxy-L-pyrimidine Nucleosides as Potential Antiviral Agents Against Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV)," J. Med. Chem., vol. 37, pp. 798-803.
Massa et al. (1995), "Synthesis and Antiviral Activity of New 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), Specific Inhibitors of Human Immunodeficiency Virus type 1," Antiviral Chemistry and Chemotherapy, vol. 6, pp. 1-8.
Mayaux et al. (1994), "Triterpene Derivatives that Block Entry of Human Immunodeficiency Virus Type 1 into Cells," Proc. Natl. Acad. Sci. USA, vol. 91, pp. 3564-3568.
McGuigan et al. (1994), "Synthesis and Anti-HIV Activity of Some Novel Diaryl Phosphate Derivatives of AZT," Antiviral Research, vol. 24, pp. 69-77.
McMahon et al. (1993), "Diarylsulfones, a New Chemical Class of Nucleoside Antiviral Inhibitors of Human Immunodeficiency Virus Type 1 reverse Transcriptase," Antimicrobial Agents and Chemotherapy, vol. 37, pp. 754-760.
Meier et al. (1992), "O-Alkyl-5',5'-dinucleoside Phosphates as Prodrugs of 3'-Azidothymidine and Cordycepin," Org. Chem., vol. 57,pp.7300-7308.
Merluzzi et al. (1990), "Inhibition of HIV-1 Replication by a Nucleoside Reverse Transcriptase Inhibitor," Science, vol. 250, ppp. 1411-1413.
Mitsunobu, O. (1981), "The Use of Diethyl Azodicarboxylate and Triphgenylphosphine in Synthesis and Transformation of Natural Products," Synthesis, pp. 1-28.
Miyasaka et al. (1989),

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for the preparation of (.+-.)-calanolide A and intermedia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the preparation of (.+-.)-calanolide A and intermedia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the preparation of (.+-.)-calanolide A and intermedia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1947872

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.